Another critical kinase in DDR is ATR; the ATR inhibitor performs radiosensitization to tumor alongside remarkable infiltration of CD3+ and NK cells in TME through activation of STING and inducing IFN response (Dillon et al., 2019). The gene discussed is ATR; the disease is neoplasm.